Andelyn Biosciences is a gene therapy and viral vector CDMO with deep expertise in the development and production of viral vectors. The company has produced 450+ cGMP clinical batches, supported 75+ INDs, and operates 225,000+ sq ft of facility space. Andelyn offers viral vector manufacturing, plasmid manufacturing, process development, and laboratory services, with a proprietary AAV Curator platform.
viral vector manufacturing (AAV), plasmid manufacturing, gene therapy CDMO, technology transfer, Optimization-By-Design, AAV Curator platform, DIGITAL CDMO platform, cGMP batch production
1 site worldwide
No reviews available yet.
No documents available.